An official website of the United States government Here’s how you know

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

In this section: Emergency Preparedness and Response

Public Health Preparedness and Response

October 2024: The FDA is working continuously to address the shortages and supply disruptions to ensure patients have access to certain parenteral drugs, including IV solutions. For the most recent information on drug and biologic products that were impacted by Hurricane Helene, please see FDA’s Baxter Recovery webpage.

The FDA plays a critical role in protecting the United States from chemical, biological, radiological, nuclear, and emerging infectious disease threats. The FDA ensures that medical countermeasures (MCMs)—including drugs, vaccines and diagnostic tests—to counter these threats are safe, effective, and secure.

Sub-Topic Paragraphs

Graphic representing history of the FDA Medical Countermeasures Initiative (MCMi)

MCM

The FDA coordinates medical countermeasure development, preparedness, and response.

MCM News and Events

Public health preparedness and response news from the FDA and our partners.

Gavel and stethoscope representing legal preparedness for public health emergencies

MCM-related counterterrorism legislation

Federal legislation enacted to strengthen the nation’s preparedness for responding to public health emergencies involving chemical, biological, radiological, nuclear (CBRN) and emerging infectious disease threats.

Emergency Use Authorization (EUA)

The EUA authority allows the FDA to help strengthen the nation’s public health protections against CBRN threats by facilitating the availability and use of MCMs needed during public health emergencies.

collage with three photos showing woman being tested for the coronavirus with a nasal swab, lab scientist wearing full personal protective gear preparing test sample with pipet, and a 3D illustration of the coronavirus

COVID-19

Get the latest COVID-19 response updates from the FDA.

Hospital emergency staff, representing public health emergency-related issues

MCM issues

MCM-related and emergency preparedness and response topics, including Ebola, mpox, antimicrobial resistance, and more.

U.S. Food and Drug Administration

Public Health Preparedness and Response

Medical Countermeasures (MCM)